Condition
Gastroesophageal Junction (GEJ) Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Gastroesophageal Junction (GEJ) Cancer clinical trials that are recruiting, at sites in 4 countries (most in United States (2), United Kingdom (1), South Korea (1)). By phase: Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Gastroesophageal Junction (GEJ) Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BHB810 in advanced gastric and GEJ cancer (early-phase) | Phase 1/2 | Duarte, California and 2 other locations | Recruiting | Apr 14, 2026 |
| Evaluating how different surgical methods affect quality of life after stomach surgery | — | Changchun, Jilin | Recruiting | Apr 16, 2025 |
| Combination of T-Dxd and Ramucirumab for HER2 Low Gastric Cancer | Phase 1/2 | Seoul, Seoul | Recruiting | Jun 8, 2023 |
| Evaluating NX-1607 for advanced cancers | Phase 1 | Duarte, California and 16 other locations | Recruiting | Nov 4, 2021 |
All recruiting trials (4)
-
BHB810 in advanced gastric and GEJ cancer (early-phase)
This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.
-
Evaluating how different surgical methods affect quality of life after stomach surgery
This study is testing how different types of stomach surgery affect the quality of life for people recovering from early-stage gastric cancer.
-
Combination of T-Dxd and Ramucirumab for HER2 Low Gastric Cancer
This study is testing a new combination treatment of T-Dxd and Ramucirumab for people with advanced HER2 low gastric cancer who haven't responded to their first treatment.
-
Evaluating NX-1607 for advanced cancers
This study is testing a new treatment called NX-1607 to see if it can help people with advanced cancers who have run out of other options.
Related topics
Quick answers
How many Gastroesophageal Junction (GEJ) Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), United Kingdom (1 trial), South Korea (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.